Illumina (ILMN -4.2%) gains a vital victory in its bid to fend off Roche's (RHHBY.PK) advances...


Illumina (ILMN -4.2%) gains a vital victory in its bid to fend off Roche's (RHHBY.PK) advances as shareholders elect all four of Illumina's nominees to its board. Investors also reject Roche's attempts to increase the number of directors and other proposals. Roche said earlier it won't extend its offer.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs